Yi-Ching Cheng Selected Research

CSC-3436

12/2021

CSC-3436 sensitizes triple negative breast cancer cells to TRAIL-induced apoptosis through ROS-mediated p38/CHOP/death receptor 5 signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ching Cheng Research Topics

Disease

3	Neoplasms (Cancer) 11/2021 - 03/2021
1	Triple Negative Breast Neoplasms 12/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021
1	Ataxia (Dyssynergia) 07/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2019

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2021
1	CSC-3436IBA 12/2021
1	FlavonoidsIBA 12/2021
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	demethoxycurcuminIBA 11/2021
1	bisdemethoxycurcuminIBA 11/2021
1	CurcuminIBA 11/2021
1	DiarylheptanoidsIBA 11/2021
1	AlkaloidsIBA 07/2021
1	Caspase 9IBA 07/2021
1	Histones (Histone)IBA 07/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2021
1	tetrandrineIBA 07/2021
1	BenzylisoquinolinesIBA 07/2021
1	Apoptosis Regulatory ProteinsIBA 07/2021
1	Caspase 3 (Caspase-3)IBA 07/2021
1	Caspase 8 (Caspase-8)IBA 07/2021
1	pterostilbeneIBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2021
1	Bronchodilator Agents (Bronchodilators)IBA 12/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2021
1	Therapeutics 11/2021